Expert NetworkExpert InterviewREPL

Slingshot members are talking to an expert! The topic is:

A Second Look: Discussing Replimune's RP1 (vusolimogene oderparepvec) in Combination with Nivolumab for Advanced Melanoma Ahead of its April FDA PDUFA Date

Executed on:Apr 6, 2026 11:00 AM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: UT Southwestern
  • Professor of Medicine, Pathology at UTSW
  • Manages 100+ CML and 50+ melanoma patients
  • Research interests include molecular pathogenesis of lymphoma and leukemia, tumor immunology and GVHD

Interview Goal

To gain a deeper understanding of Replimune's RP1 (vusolimogene oderparepvec) in Combination with Nivolumab for Advanced Melanoma

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.